Rating History for Ligand Pharma (LGND) by Citi

More Stocks Rated by Citi | Latest Ratings for LGND
Date Analyst Type Rating
(Past)		 PT
(Past)		 Start $
(End $)		 % Chg. Details
12/9/2025 Yigal Nochomovitz New Coverage Buy
(N/A)		 270.00
(N/A)		 184.67
(201.90)		 9.33% Details